期刊文献+

舍尼通治疗合并前列腺炎的BPH患者术后下尿路症状的临床研究 被引量:6

CLINICAL STUDY OF PROSTAT FOR TREATING LUTS IN THE POSTOPERATIVE PATIENTS OFBENIGN PROSTATIC HYPERPLASIA WITH HISTOLOGICAL PROSTATITIS
暂未订购
导出
摘要 目的:评估舍尼通治疗合并组织学前列腺炎的良性前列腺增生(BPH)患者前列腺电切术(TURP)术后仍存在的下尿路症状的疗效。方法:将接受经尿道前列腺电切术,术后病理诊断证实BPH并合并组织学前列腺炎的180例患者随机分为两组,其中A组:空白对照组90例,B组:舍尼通治疗组90例。用IPSS评分系统评估各组术后第1个月及治疗1个月后的下尿路症状。结果:A组观察1个月后和B组舍尼通治疗1个月后的IPSS评分分别为(12.04±4.73)分和(6.56±2.84)分,差异有统计学意义(P<0.001)。A组有效率2.2%,B组有效率91.1%。结论:舍尼通能明显改善合并组织学炎症的BPH患者手术后仍存在的下尿路症状,且无药物不良反应。 Objective:To evaluate the efficacy of prostat in the treatment of lower urinary tract symptoms (LUTS) in the postoperative patients of benign prostatic hyperplasia (BPH) with histological prostatitis. Methods: A total of 180 patients diagnosed of BPH with histological prostatitis by pathological diagnosis af- ter transurethral resection of prostate (TURP) were enrolled in the trial. The cases was randomly divided into control group ( n =90) and prostat treatment group B ( n=90). The LUTS of each group was evalua- ted by IPSS scoring system in the first month and the second month after the TURP. Results: After obser-vation of one month, the IPSS scores of control group were 12. 04 ±4 4. 73. The IPSS scores of treatment group were 6.56±42.84 after one month treatment by prostat. The difference was statistically significant( P 〈0. 001). The effective rate was 2.2% and 91. 1% respectively. Conclusion: Prostat is effective and safe in relieving the LUTS in the postoperative patients of BPH with histological prostatitis.
出处 《广西医科大学学报》 CAS 2013年第2期218-220,共3页 Journal of Guangxi Medical University
基金 广西自然科学基金资助项目(No.2010GXNSFA013247)
关键词 前列腺增生 前列腺炎 下尿路症状 舍尼通 prostatic hyperplasia prostatitis lower urinary tract symptoms prostat
  • 相关文献

参考文献11

  • 1Gerstenbluth RE, Steftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatecto- my specimens with up-regulation of Bcl-2 in areas of in- flammation[J]. J Urol,2002,167(5) :2 267-2 270.
  • 2Rugendorff EW,Weidner W,Ebiling L,et al. Results of treatment with pollen extract (cernilton) in chronic prostatitis and prostatodynia[J]. Br J Urol, 1993,71:433-438.
  • 3叶章群,蓝儒竹,王少刚,蔡松良,陈戈明,李宁忱,宋毅,那彦群.舍尼通~和抗生素联合用药治疗慢性非细菌性前列腺炎临床研究[J].中华男科学杂志,2006,12(9):807-810. 被引量:21
  • 4徐骏,钱伟庆,宋建达.比较不同剂量舍尼通在防止良性前列腺增生疾病进程中的作用[J].中华男科学杂志,2008,14(6):533-537. 被引量:16
  • 5Nickel JC, True I.D, Krieger JN, et al. Consensus de- velopment of a histopathoIogical classification system for chronic prostatic inflammation[J]. BJU Int, 2001,87 (9) :797-805.
  • 6揭晓,莫曾南.前列腺炎症与前列腺增生的关系[J].实用医学杂志,2008,24(20):3608-3610. 被引量:6
  • 7Nickel JC,Downey J, Young I, et al. Asymptomatic in- nammation and/or infection in benign prostatic hyper- plasia[J]. BJU Int, 1999,84 : 976-981.
  • 8龙智,何乐业,钟狂飚,张一川,岳栋.合并前列腺炎的良性前列腺增生症的临床分析[J].中南大学学报(医学版),2010,35(4):381-385. 被引量:28
  • 9Elist J. Elects of pollen extract preparation Prostat/Pol- tit on lower urinary tractsymptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syn drome: a randomized, doubleblind, placebo-controlled study[J]. Urology,2006,67(1) :60 -63.
  • 10Loschen G, Eheling L. Inhibition of the arachidonate metabolism by an extract from rye pollen[J]. Arzneim- ittelforschung, 1991,41(2) : 162-167.

二级参考文献50

  • 1张骞,彭靖,张祥华,郭应禄,金杰.环氧化酶-2对大鼠前列腺增生的影响及作用机理研究[J].中华泌尿外科杂志,2005,26(7):468-471. 被引量:7
  • 2王志平,陈一戎,刘国栋.花粉提取物对前列腺增生细胞作用的研究[J].中华泌尿外科杂志,1995,16(12):732-733. 被引量:15
  • 3Theyer G, Kramer G, Assmann I, et al. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia [J]. Lab Invest, 1992, 66(1): 96-107.
  • 4Nickel J C, Roehrborn C G, O'Leary M, et al. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE cbemoprevention trial [Jl- J Urol,2007,178(3 Pt 1) :896-900.
  • 5Khadra A, Fletcher P, Luzzi G, et al. Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis [J]. BJU Int, 2006, 97(5): 1043-1046.
  • 6Girl D, Ittmann M. Interleukin-lalpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia [J]. Am J Pathol,2000,157 ( 1 ) : 249-255.
  • 7Ropiquet F, Giri D, Lamb D J, et al. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation [J]. J Urol, 1999, 162(2)- 595-599.
  • 8Fujita H, Koshida K, Keller E T, et al. Cyelooxygenase-2 promotes prostate cancer progression [J]. Prostate, 2002, 53(3): 232-240.
  • 9Huang X, Lee C. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta [J]. Front Biosci, 2003, 8: s740-749.
  • 10Wang W, Bergh A, Damber J E. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer [J]. Clin Cancer Res,2005,11 (9) : 3250-3256.

共引文献67

同被引文献58

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部